ION EXCHANGE (INDIA) LTD.-$

Ion Exchange (India) Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the half-year ending September 30, 2026. The specific date for the board meeting to approve these results will be communicated later.

Ion Exchange India Ltd is sending a letter to shareholders who have not registered their email addresses, providing a web-link to access the Notice of the 62nd Annual General Meeting and the Annual Report for FY 2025-26. The AGM is scheduled for September 11, 2026, via Video Conferencing. Key dates include a record date of August 31, 2026, and e-voting from September 7 to September 10, 2026. Shareholders are guided on how to update their email addresses with their Depository Participant or the Registrar and Transfer Agent, MUFG Intime India Private Limited.

Ion Exchange India Ltd has filed its Annual Report for the financial year 2025-26, along with the Notice of the 62nd Annual General Meeting (AGM) and other statutory reports. The report highlights the company's focus on sustainability, resource recovery, and water management. Key initiatives include the commissioning of a new state-of-the-art Resin manufacturing facility at Roha, emphasizing circular economy principles, non-solvent manufacturing, and Zero Liquid Discharge (ZLD). The company is also expanding its membrane manufacturing capabilities to cater to the growing demand in desalination and water reuse markets. The Executive Chairman's message underscores the increasing urgency for sustainable water management and the promising opportunities within the industry.

Ion Exchange India Ltd has announced its 62nd Annual General Meeting (AGM) will be held on Friday, September 11, 2026, at 11:00 a.m. IST. The meeting will be conducted through Video Conference (VC) / Other Audio-Visual Means (OAVM) in compliance with MCA and SEBI circulars. Key agenda items include the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, declaration of dividend on equity shares, and the re-appointment of Mr. Dinesh Sharma as a Director. Additionally, the remuneration of the Cost Auditors, M/s. R. Nanabhoy & Co., for the financial year ending March 31, 2027, amounting to ₹4,75,000 plus applicable taxes, will be ratified.

Ion Exchange India Ltd has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report, which is part of the Annual Report, details the company's Environmental, Social, and Governance (ESG) strategy and performance. The company emphasizes its commitment to conserving resources through water and environmental management solutions, highlighting its role as a leading provider in the sector. The BRSR showcases progress in reducing carbon, energy, and water intensities while expanding operations and workforce, integrating sustainability as a core growth driver. The report is available on the company's website.

Ion Exchange India Ltd has released its Earnings Presentation for the first quarter ended June 30, 2026. The presentation, shared with investors and analysts, details the company's financial performance and operational highlights. Ion Exchange is a global leader in Total Water & Environment Management, with over 62 years of expertise, operations in 50+ countries, and a vast service network. The company offers a comprehensive portfolio including process water treatment, high purity water, industrial wastewater treatment, drinking water solutions, and source water pretreatment. Their capabilities span resins, membranes, chemicals, solutions, services, and digital offerings, supported by advanced R&D and world-class manufacturing facilities.

ION Exchange (India) Limited has announced its unaudited financial results for the first quarter ended June 30, 2026. The results, which are both standalone and consolidated, were approved by the Board of Directors at a meeting held on August 5, 2026. The company has submitted these results along with a limited review report to the stock exchange. The financial information for certain staff welfare trusts, which are part of the consolidated results, showed total revenue of ₹31.73 lacs and a net profit after tax of ₹30.43 lacs for the quarter. The company management has stated that this information is not material to the overall company.

Consolidated PAT (the primary basis) came in at ₹3.06 Cr, down 93.7% YoY from ₹48.44 Cr and 87.4% QoQ from ₹24.29 Cr, even as consolidated revenue grew 20.1% YoY to ₹700.46 Cr (down 18.9% sequentially off a seasonally heavier Q4). Standalone tells a materially milder story — PAT fell 75.7% YoY to ₹11.40 Cr versus the consolidated 93.7% drop — a gap large enough that readers seeing either number elsewhere should not assume one is wrong; it stems from subsidiary-level losses and a ₹1.05 Cr loss attributable to non-controlling interests (owners' share of consolidated profit was ₹4.11 Cr). Net profit margin fell to 0.43% of total income from 8.06% a year ago and 2.68% last quarter. The compression is concentrated in two segments: Treatment Solutions (the renamed, reorganised former Engineering business) swung to a ₹17.35 Cr consolidated loss from a ₹16.81 Cr profit in Q1 FY26 and a smaller ₹1.19 Cr loss last quarter; Specialty Chemicals profit nearly halved YoY to ₹22.27 Cr from ₹46.25 Cr even as segment revenue grew 21.6% to ₹229.65 Cr — volume growth without margin, consistent with the input-cost pass-through problem management flagged on the May 2026 call. Consumer Products stayed loss-making but the loss narrowed to ₹0.34 Cr from ₹0.45 Cr YoY, tracking toward management's stated break-even goal. On the May 2026 (Q4 FY26) call, management said it could not yet give FY27 sales/margin guidance for the chemicals and engineering divisions given the "dynamic geopolitical situation," with clarity expected only in H2 FY27, while noting it was actively working to pass on input cost increases; it also said it expected "continued improvement in sales and margins over the next few months." This quarter delivered on the sales half of that statement but missed on margins. No analyst/consensus estimates for this specific quarter surfaced in a web search, so the print's standing versus Street is unknown; the company issued no press release alongside this filing, so there is no fresh management framing to reconcile against the numbers. Two other developments this quarter sit outside the P&L: a $52.83 Mn Hyundai order win on July 10, 2026 (a forward order-book data point for the segments currently under margin pressure) and a ₹1.25/share FY26 dividend recommendation on May 26, 2026.

Ion Exchange India Ltd has announced that its Board of Directors will convene on August 5, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2026. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also made this information available on its official website.

ION Exchange (India) Limited has secured a significant international contract from Hyundai Engineering & Construction Co. Ltd. for the supply of filtration units in the Middle East. The contract is valued at USD 52.83 million (approximately INR 503 crore) and is slated for execution over an 18-month period. This award highlights the company's growing international presence and its capability to undertake large-scale projects for global engineering firms.